Loading…
Welcure Drugs & Pharmaceuticals (BSE 524661)₹0.1900−5.00%Pharmaceuticals
At the end of the Mar 2026 quarter, Welcure Drugs & Pharmaceuticals' shareholders were: public 100.00%. 0.00% of promoter shares were pledged. It had 88,009 shareholders.
As of · Company filings (shareholding pattern)
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Public | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| Promoter shares pledged | — | — | — | — | — | — | — | — | — | — | — | 0.00% |
| Number of shareholders | 29,262 | 29,604 | 29,968 | 31,541 | 31,056 | 30,229 | 30,616 | 32,378 | 37,311 | 76,982 | 87,320 | 88,009 |
| Holder | Category | Mar 2026 | Change (pp) |
|---|---|---|---|
| Kifs Trade Capital Private Limited | Public | Exited | — |
No. The Mar 2026 filing shows no pledged promoter shares.
Welcure Drugs & Pharmaceuticals had 88,009 shareholders at the end of the Mar 2026 quarter, against 32,378 a year earlier.